MedTrace Logo

Relationship Between Circulating Tumor Cell Cultures' Treatment Response and Clinical Outcomes

NCT04280640 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2021-10-18

No results posted yet for this study

Summary

The purpose of this prospective, non-randomized, single-center pilot exploratory study is to investigate whether established circulating tumor cell (CTC) cultures have a similar response to targeted therapy treatment as the in vivo (patients') disease.

Conditions

Interventions

OTHER

Blood Draw

A blood sample will be collected once, prior to treatment.

Sponsors & Collaborators

  • UNC Lineberger Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Andrew Z Wang, MD · UNC Chapel Hill

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-30
Primary Completion
2023-06-30
Completion
2023-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04280640 on ClinicalTrials.gov